Abalone Bio
Toshihiko Takeuchi, currently the Chief Scientific Officer at Abalone Bio, previously held roles such as VP Discovery Services at Second Genome Inc. and Vice President, Discovery Research at XOMA. With a background in Chemistry, Toshihiko has extensive experience in Antibody Discovery and Engineering, as well as leading teams in Protein sciences, Discovery Biology, and Microbiology and Sequencing. Throughout their career, Toshihiko has led projects resulting in the discovery and development of various therapeutic antibodies in collaboration with different pharmaceutical companies.
This person is not in any offices
Abalone Bio
Abalone Bio develops antibody drugs that activate, enabling us to turn on previously inaccessible biological activities like anti-cancer or anti-inflammatory actions.